Mechanisms that determine subcellular sites of HIV-1 assembly

决定 HIV-1 组装亚细胞位点的机制

基本信息

  • 批准号:
    10203782
  • 负责人:
  • 金额:
    $ 53.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-02-01 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Title: Mechanisms that determine subcellular sites of HIV-1 assembly Summary/Abstract: Virus particle assembly of HIV-1, the causative agent of AIDS, takes place at the plasma membrane (PM) in most cell types including natural host T cells. This process is driven by a viral structural protein Gag. The N- terminal matrix (MA) domain of Gag determines Gag localization to and hence virus assembly at the PM. MA mediates membrane binding of Gag via N-terminal myristoyl moiety and a highly basic region (HBR) that binds acidic lipids. Binding of HBR to a PM-specific acidic phospholipid PI(4,5)P2 is critical for PM localization of Gag and efficient virus release. Notably, in vitro and cell-based studies showed that MA HBR also interacts with tRNAs, which suppress binding of Gag to non-PI(4,5)P2 acidic lipids, suggesting tRNAs as a new host factor that regulates MA-membrane interactions. However, molecular determinants for the tRNA-MA HBR interaction and its reversal by the interaction with PI(4,5)P2, combination of which regulates PM-specific Gag localization, remain to be elucidated. Moreover, how these interactions begin and what effect these interactions have on the property of progeny virions at the end are poorly understood. Binding of tRNAs to MA HBR is most likely to occur at translation sites due to limited availability of tRNAs outside of the translation machinery. However, little is known about subcellular sites of Gag translation, where Gag begins its movement to the PM. At the PM, Gag multimerization is likely to create accumulation of acidic lipids, but its impact on the ability of progeny virions to spread to uninfected cells remains unknown. Our long-term goal is to elucidate mechanisms that determine sites of HIV-1 assembly and to use the knowledge for developing antiviral strategies. Our central hypothesis in this application is that MA HBR interactions with tRNAs, which begin during translation, and with acidic lipids determine subcellular Gag localization and the properties of progeny virions. To test this hypothesis, we plan to: 1) identify molecular determinants for interaction of MA HBR with tRNAs and its reversal by PI(4,5)P2; 2) identify tRNAs that suppress PI(4,5)P2-independent membrane binding but allow PI(4,5)P2-mediated reversal; 3) examine the possibility that Gag associates with tRNA during translation; and 4) examine the effect of acidic lipid accumulation at virus assembly sites on the virion properties. The knowledge gained from experiments outlined in this proposal will likely help us develop antiviral strategies that target mechanisms regulating Gag localization to the PM, thereby inhibiting extracellular virus release and spread.
标题:确定HIV-1组装亚细胞位点的机制 总结/摘要: HIV-1(艾滋病的病原体)的病毒颗粒组装发生在细胞质膜(PM)上, 大多数细胞类型包括天然宿主T细胞。这个过程是由病毒结构蛋白Gag驱动的。N- Gag的末端基质(MA)结构域决定Gag定位于PM并因此决定病毒组装于PM。马 通过N-末端肉豆蔻酰基部分和结合Gag的高碱性区域(HBR)介导Gag的膜结合 酸性脂质HBR与PM特异性酸性磷脂PI(4,5)P2的结合对于Gag的PM定位至关重要 和高效的病毒释放。值得注意的是,体外和基于细胞的研究表明,MA HBR也与 tRNA抑制Gag与非PI(4,5)P2酸性脂质的结合,表明tRNA是一种新的宿主因子 调节MA-膜相互作用。然而,tRNA-MA HBR相互作用的分子决定因素 以及通过与PI(4,5)P2相互作用的逆转,其组合调节PM特异性Gag定位, 仍有待阐明。此外,这些相互作用如何开始以及这些相互作用对 对末端的子代病毒体的性质知之甚少。tRNA与MA HBR的结合最有可能 由于翻译机器外的tRNA的可用性有限,因此在翻译位点发生。不过小 已知Gag翻译的亚细胞位点,其中Gag开始向PM移动。下午,加格 多聚化可能会产生酸性脂质的积累,但其对子代病毒粒子的能力的影响, 扩散到未感染的细胞仍然未知。 我们的长期目标是阐明决定HIV-1组装位点的机制,并使用 开发抗病毒策略的知识。我们在这个应用中的中心假设是,MA HBR 在翻译过程中开始与tRNA的相互作用,以及与酸性脂质的相互作用决定了亚细胞Gag 定位和子代病毒体的性质。为了验证这一假设,我们计划:1)识别分子 MA HBR与tRNA相互作用及其被PI(4,5)P2逆转的决定因素; 2)鉴定 抑制PI(4,5)P2非依赖性膜结合,但允许PI(4,5)P2介导的逆转; 3)检查 Gag在翻译过程中与tRNA结合的可能性;以及4)检查酸性脂质的影响 在病毒装配位点的积累对病毒体性质的影响。从实验中获得的知识概述了 这项提议可能会帮助我们开发针对调节Gag机制的抗病毒策略, 定位于PM,从而抑制细胞外病毒释放和传播。

项目成果

期刊论文数量(17)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Roles played by acidic lipids in HIV-1 Gag membrane binding.
酸性脂质在 HIV-1 Gag 膜结合中发挥的作用。
  • DOI:
    10.1016/j.virusres.2014.06.015
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    5
  • 作者:
    Olety,Balaji;Ono,Akira
  • 通讯作者:
    Ono,Akira
Phosphatidylinositol-(4,5)-Bisphosphate Acyl Chains Differentiate Membrane Binding of HIV-1 Gag from That of the Phospholipase Cδ1 Pleckstrin Homology Domain.
磷脂酰肌醇-(4,5)-二磷酸酰基链区分 HIV-1 Gag 的膜结合与磷脂酶 Cδ1 Pleckstrin 同源域的膜结合。
  • DOI:
    10.1128/jvi.00794-15
  • 发表时间:
    2015
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Olety,Balaji;Veatch,SarahL;Ono,Akira
  • 通讯作者:
    Ono,Akira
Molecular mechanisms by which HERV-K Gag interferes with HIV-1 Gag assembly and particle infectivity.
  • DOI:
    10.1186/s12977-017-0351-8
  • 发表时间:
    2017-04-26
  • 期刊:
  • 影响因子:
    3.3
  • 作者:
    Monde K;Terasawa H;Nakano Y;Soheilian F;Nagashima K;Maeda Y;Ono A
  • 通讯作者:
    Ono A
HIV-1 assembly at the plasma membrane.
HIV-1 在质膜上组装。
  • DOI:
    10.1016/j.vaccine.2009.10.021
  • 发表时间:
    2010
  • 期刊:
  • 影响因子:
    5.5
  • 作者:
    Ono,Akira
  • 通讯作者:
    Ono,Akira
Relationships between plasma membrane microdomains and HIV-1 assembly.
  • DOI:
    10.1042/bc20090165
  • 发表时间:
    2010-03-25
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Ono A
  • 通讯作者:
    Ono A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Akira Ono其他文献

Akira Ono的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Akira Ono', 18)}}的其他基金

Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    10617799
  • 财政年份:
    2022
  • 资助金额:
    $ 53.78万
  • 项目类别:
Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    10362907
  • 财政年份:
    2022
  • 资助金额:
    $ 53.78万
  • 项目类别:
Effects of lymphoid tissue stromal cells on cell-to-cell HIV-1 spread
淋巴组织基质细胞对细胞间 HIV-1 传播的影响
  • 批准号:
    9090035
  • 财政年份:
    2015
  • 资助金额:
    $ 53.78万
  • 项目类别:
Recruitment of BST-2/tetherin to HIV-1 assembly sites
将 BST-2/tetherin 招募到 HIV-1 装配位点
  • 批准号:
    8291214
  • 财政年份:
    2011
  • 资助金额:
    $ 53.78万
  • 项目类别:
Recruitment of BST-2/tetherin to HIV-1 assembly sites
将 BST-2/tetherin 招募到 HIV-1 装配位点
  • 批准号:
    8210153
  • 财政年份:
    2011
  • 资助金额:
    $ 53.78万
  • 项目类别:
Relationships between HIV-1 assembly and the plasma membrane organization
HIV-1组装与质膜组织之间的关系
  • 批准号:
    8138123
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    8068079
  • 财政年份:
    2010
  • 资助金额:
    $ 53.78万
  • 项目类别:
Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    7350922
  • 财政年份:
    2007
  • 资助金额:
    $ 53.78万
  • 项目类别:
Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    8013495
  • 财政年份:
    2007
  • 资助金额:
    $ 53.78万
  • 项目类别:
Mechanisms that determine subcellular sites of HIV-1 assembly
决定 HIV-1 组装亚细胞位点的机制
  • 批准号:
    8822791
  • 财政年份:
    2007
  • 资助金额:
    $ 53.78万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 53.78万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 53.78万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 53.78万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 53.78万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 53.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了